PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 127 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $62,000 | -32.6% | 10,070 | -31.7% | 0.00% | 0.0% |
| Q3 2018 | $92,000 | -21.4% | 14,740 | +0.9% | 0.00% | -33.3% |
| Q2 2018 | $117,000 | +6.4% | 14,610 | -0.7% | 0.00% | 0.0% |
| Q1 2018 | $110,000 | +11.1% | 14,720 | -11.4% | 0.00% | +50.0% |
| Q4 2017 | $99,000 | -67.5% | 16,610 | -60.0% | 0.00% | -75.0% |
| Q3 2017 | $305,000 | 0.0% | 41,480 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $305,000 | – | 41,480 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|